Articles published by Merck & Co., Inc.


Merck Announces Second-Quarter 2022 Dividend
January 25, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK

Merck Provides U.S. and Japan Regulatory Update for Gefapixant
January 24, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK






Merck to Hold Fourth-Quarter and Full-Year 2021 Sales and Earnings Conference Call on February 3
January 07, 2022
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK





Merck and Ridgeback Announce U.K. Government to Purchase Additional 1.75 Million Courses of Molnupiravir
December 22, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK





Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection
December 13, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK

Merck Issues $1 Billion Inaugural Sustainability Bond
December 13, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK

Merck Prices $8.0 Billion Debt Offering
December 07, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK

Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities
December 07, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK





Merck Announces First-Quarter 2022 Dividend
November 30, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.